P
Peter M. Rothwell
Researcher at University of Oxford
Publications - 815
Citations - 77220
Peter M. Rothwell is an academic researcher from University of Oxford. The author has contributed to research in topics: Stroke & Population. The author has an hindex of 134, co-authored 779 publications receiving 67382 citations. Previous affiliations of Peter M. Rothwell include Leicester Royal Infirmary & University of Edinburgh.
Papers
More filters
Journal ArticleDOI
Pathogenic Ischemic Stroke Phenotypes in the NINDS-Stroke Genetics Network.
Hakan Ay,Ethem Murat Arsava,Gunnar Andsberg,Thomas Benner,Robert D. Brown,Sherita Chapman,John W. Cole,Hossein Delavaran,Martin Dichgans,Gunnar Engström,Eva Giralt-Steinhauer,Raji P. Grewal,Katrina Gwinn,Christina Jern,Jordi Jimenez-Conde,Katarina Jood,Michael Katsnelson,Brett M. Kissela,Steven J. Kittner,Dawn Kleindorfer,Daniel L. Labovitz,Silvia Lanfranconi,Jin-Moo Lee,Manuel Lehm,Robin Lemmens,Christopher R Levi,Linxin Li,Arne Lindgren,Hugh S. Markus,Patrick F. McArdle,Olle Melander,Bo Norrving,Leema Reddy Peddareddygari,Annie Pedersen,Joanna Pera,Kristiina Rannikmäe,Kathryn M. Rexrode,David Rhodes,Stephen S. Rich,Jaume Roquer,Jonathan Rosand,Peter M. Rothwell,Tatjana Rundek,Ralph L. Sacco,Reinhold Schmidt,Markus Schürks,Stephan Seiler,Pankaj Sharma,Agnieszka Slowik,Cathie Sudlow,Vincent Thijs,Rebecca Woodfield,Bradford B. Worrall,James F. Meschia +53 more
TL;DR: This study demonstrates that pathogenic subtypes can be determined with good reliability in studies that include investigators with different expertise and background, institutions with different stroke evaluation protocols and geographic location, and patient populations with different epidemiological characteristics.
Journal ArticleDOI
Long-Term Consequences of Worsened Poststroke Status in Patients With Premorbid Disability.
TL;DR: In this article, patients with premorbid disability, generally defined as modified Rankin Scale (mRS) score ≥ 2, are often excluded from trials of acute stroke therapies, and increased d...
Journal ArticleDOI
Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack
Rebecca L. Brookes,Siobhan Crichton,Charles D.A. Wolfe,Qilong Yi,Linxin Li,Graeme J. Hankey,Graeme J. Hankey,Peter M. Rothwell,Hugh S. Markus +8 more
TL;DR: Exposure to SVA, an inhibitor of HDAC, may be associated with a lower recurrent stroke risk although one cannot exclude residual confounding in this study design.
Journal ArticleDOI
Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies.
Linxin Li,Michael T C Poon,Neshika Samarasekera,Luke A Perry,Tom J Moullaali,Tom J Moullaali,Mark Rodrigues,Mark Rodrigues,James J M Loan,Jacqueline Stephen,Christine Lerpiniere,M A Tuna,Sergei A. Gutnikov,Wilhelm Küker,Louise E. Silver,Rustam Al-Shahi Salman,Peter M. Rothwell +16 more
TL;DR: In this paper, the authors quantified the absolute and relative risks of recurrent ICH, ischaemic stroke, or any serious vascular event (nonfatal stroke, non-fatal myocardial infarction, or vascular death), stratified by ICH location and comorbid atrial fibrillation (AF).